Agilent Technologies has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
The new structure organizes the company’s businesses according to its end markets and customers.
Agilent’s shares have declined 3.25% for the year-to-date period, underperforming the broader market.
Monday U.S. Featured Earnings Agilent Technologies Inc (NYSE: A) (Q4) EPS of $1.41, compared ...
Agilent Technologies will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up by +0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.79%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.07%. Stocks...
Danaher Corporation DHR is poised to benefit from strength in its clinical diagnostics business, backed by growth in Leica Biosystems and Beckman Colter Diagnostics units. The company has been witnessing...
Investors in Agilent Technologies, Inc. A need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $170.00 Put had some of the highest implied...
Waters has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.